| 000 | 01671 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250516013552.0 | ||
| 264 | 0 | _c20110317 | |
| 008 | 201103s 0 0 eng d | ||
| 022 | _a1744-8344 | ||
| 024 | 7 |
_a10.1586/erc.10.154 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFirbas, Christa | |
| 245 | 0 | 0 |
_aTargeting von Willebrand factor and platelet glycoprotein Ib receptor. _h[electronic resource] |
| 260 |
_bExpert review of cardiovascular therapy _cDec 2010 |
||
| 300 |
_a1689-701 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aADAM Proteins _xgenetics |
| 650 | 0 | 4 | _aADAMTS13 Protein |
| 650 | 0 | 4 | _aAcute Coronary Syndrome |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xpharmacology |
| 650 | 0 | 4 |
_aAptamers, Nucleotide _xpharmacology |
| 650 | 0 | 4 |
_aBernard-Soulier Syndrome _xdrug therapy |
| 650 | 0 | 4 |
_aBlood Coagulation Disorders _xdrug therapy |
| 650 | 0 | 4 |
_aCardiovascular Diseases _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMembrane Glycoproteins _xantagonists & inhibitors |
| 650 | 0 | 4 | _aMolecular Targeted Therapy |
| 650 | 0 | 4 |
_aPlatelet Activation _xdrug effects |
| 650 | 0 | 4 |
_aPlatelet Aggregation Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aPlatelet Glycoprotein GPIb-IX Complex _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aPurpura, Thrombotic Thrombocytopenic _xdrug therapy |
| 650 | 0 | 4 |
_avon Willebrand Factor _xantagonists & inhibitors |
| 700 | 1 | _aSiller-Matula, Jolanta M | |
| 700 | 1 | _aJilma, Bernd | |
| 773 | 0 |
_tExpert review of cardiovascular therapy _gvol. 8 _gno. 12 _gp. 1689-701 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1586/erc.10.154 _zAvailable from publisher's website |
| 999 |
_c20401501 _d20401501 |
||